Literature DB >> 27630182

Defining Glomerular Disease in Mechanistic Terms: Implementing an Integrative Biology Approach in Nephrology.

Laura H Mariani1, William F Pendergraft2, Matthias Kretzler3.   

Abstract

Advances in biomedical research allow for the capture of an unprecedented level of genetic, molecular, and clinical information from large patient cohorts, where the quest for precision medicine can be pursued. An overarching goal of precision medicine is to integrate the large-scale genetic and molecular data with deep phenotypic information to identify a new mechanistic disease classification. This classification can ideally be used to meet the clinical goal of the right medication for the right patient at the right time. Glomerular disease presents a formidable challenge for precision medicine. Patients present with similar signs and symptoms, which cross the current disease categories. The diseases are grouped by shared histopathologic features, but individual patients have dramatic variability in presentation, progression, and response to therapy, reflecting the underlying biologic heterogeneity within each glomerular disease category. Despite the clinical challenge, glomerular disease has several unique advantages to building multilayered datasets connecting genetic, molecular, and structural information needed to address the goals of precision medicine in this population. Kidney biopsy tissue, obtained during routine clinical care, provides a direct window into the molecular mechanisms active in the affected organ. In addition, urine is a biofluid ideally suited for repeated measurement from the diseased organ as a liquid biopsy with potential to reflect the dynamic state of renal tissue. In our review, current approaches for large-scale data generation and integration along the genotype-phenotype continuum in glomerular disease will be summarized. Several successful examples of this integrative biology approach within glomerular disease will be highlighted along with an outlook on how achieving a mechanistic disease classification could help to shape glomerular disease research and care in the future.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  Biological Products; Biology; Biomedical Research; Biopsy; Genotype; Goals; Humans; Kidney Glomerulus; Phenotype; Precision Medicine; genetics and development; glomerular disease; glomerulonephritis; glomerulopathy; molecular genetics; nephrology; transcriptional profiling

Mesh:

Year:  2016        PMID: 27630182      PMCID: PMC5108211          DOI: 10.2215/CJN.13651215

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  37 in total

1.  Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression.

Authors:  Robert Küffner; Neta Zach; Raquel Norel; Johann Hawe; David Schoenfeld; Liuxia Wang; Guang Li; Lilly Fang; Lester Mackey; Orla Hardiman; Merit Cudkowicz; Alexander Sherman; Gokhan Ertaylan; Moritz Grosse-Wentrup; Torsten Hothorn; Jules van Ligtenberg; Jakob H Macke; Timm Meyer; Bernhard Schölkopf; Linh Tran; Rubio Vaughan; Gustavo Stolovitzky; Melanie L Leitner
Journal:  Nat Biotechnol       Date:  2014-11-02       Impact factor: 54.908

Review 2.  Understanding the epigenetic syntax for the genetic alphabet in the kidney.

Authors:  Katalin Susztak
Journal:  J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 10.121

Review 3.  Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review.

Authors:  Paul A Monach; Lindsay M Arnold; Peter A Merkel
Journal:  Arthritis Rheum       Date:  2010-01

Review 4.  Membranous Nephropathy: A Journey From Bench to Bedside.

Authors:  Jean M Francis; Laurence H Beck; David J Salant
Journal:  Am J Kidney Dis       Date:  2016-04-13       Impact factor: 8.860

Review 5.  Research Infrastructure for Collaborative Team Science: Challenges in Technology-Supported Workflows in and Across Laboratories, Institutions, and Geographies.

Authors:  Barbara Mirel; Airong Luo; Marcelline Harris
Journal:  Semin Nephrol       Date:  2015-05       Impact factor: 5.299

Review 6.  Metabolomics in chronic kidney disease.

Authors:  Ying-Yong Zhao
Journal:  Clin Chim Acta       Date:  2013-04-06       Impact factor: 3.786

7.  Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease.

Authors:  Kumar Sharma; Bethany Karl; Anna V Mathew; Jon A Gangoiti; Christina L Wassel; Rintaro Saito; Minya Pu; Shoba Sharma; Young-Hyun You; Lin Wang; Maggie Diamond-Stanic; Maja T Lindenmeyer; Carol Forsblom; Wei Wu; Joachim H Ix; Trey Ideker; Jeffrey B Kopp; Sanjay K Nigam; Clemens D Cohen; Per-Henrik Groop; Bruce A Barshop; Loki Natarajan; William L Nyhan; Robert K Naviaux
Journal:  J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 10.121

Review 8.  Genetic kidney diseases.

Authors:  Friedhelm Hildebrandt
Journal:  Lancet       Date:  2010-04-10       Impact factor: 79.321

Review 9.  Matching the Genotype in Resolution: Innovative Ways of Phenotype Capture.

Authors:  Margaret T Hicken; Debbie S Gipson
Journal:  Semin Nephrol       Date:  2015-05       Impact factor: 5.299

Review 10.  The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.

Authors:  Katarzyna Tomczak; Patrycja Czerwińska; Maciej Wiznerowicz
Journal:  Contemp Oncol (Pozn)       Date:  2015
View more
  18 in total

1.  Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study.

Authors:  Anna Broder; Wenzhu B Mowrey; Hina N Khan; Bojana Jovanovic; Alejandra Londono-Jimenez; Peter Izmirly; Chaim Putterman
Journal:  Semin Arthritis Rheum       Date:  2017-07-14       Impact factor: 5.532

Review 2.  Opportunities and challenges in phenotypic drug discovery: an industry perspective.

Authors:  John G Moffat; Fabien Vincent; Jonathan A Lee; Jörg Eder; Marco Prunotto
Journal:  Nat Rev Drug Discov       Date:  2017-07-07       Impact factor: 84.694

Review 3.  Genetics of kidney disease in 2016: Ingenious tactics to unravel complex kidney disease genetics.

Authors:  Kirsten Y Renkema; Nine V A M Knoers
Journal:  Nat Rev Nephrol       Date:  2017-01-19       Impact factor: 28.314

4.  Mesangial renal disease, oxygen sensing, and prolyl hydroxylase.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2017-03       Impact factor: 4.599

Review 5.  Focal Segmental Glomerulosclerosis.

Authors:  Avi Z Rosenberg; Jeffrey B Kopp
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-27       Impact factor: 8.237

6.  Emerging drugs for treatment of focal segmental glomerulosclerosis.

Authors:  Howard Trachtman
Journal:  Expert Opin Emerg Drugs       Date:  2020-08-12       Impact factor: 4.191

7.  Systems Biology and Kidney Disease.

Authors:  Jennifer A Schaub; Habib Hamidi; Lalita Subramanian; Matthias Kretzler
Journal:  Clin J Am Soc Nephrol       Date:  2020-01-28       Impact factor: 8.237

Review 8.  Digital pathology in nephrology clinical trials, research, and pathology practice.

Authors:  Laura Barisoni; Jeffrey B Hodgin
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-11       Impact factor: 2.894

Review 9.  Lessons from CKD-Related Genetic Association Studies-Moving Forward.

Authors:  Sophie Limou; Nicolas Vince; Afshin Parsa
Journal:  Clin J Am Soc Nephrol       Date:  2017-12-14       Impact factor: 8.237

Review 10.  Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System Intervention.

Authors:  Sergei I Petrykiv; Gozewijn Dirk Laverman; Frederik Persson; Liffert Vogt; Peter Rossing; Martin H de Borst; Ronald T Gansevoort; Dick de Zeeuw; Hiddo J L Heerspink
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-11       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.